Add-on vildagliptin improves outcomes in patients with diabetes, CAD
Patients with type 2 diabetes mellitus (T2DM) and symptomatic coronary artery disease (CAD) treated with metformin fare better with the addition of vildagliptin versus glimepiride, as the former is associated with better glycaemic control and lipid profile, according to a study.
Add-on vildagliptin improves outcomes in patients with diabetes, CAD
28 Jan 2021
